Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Multiple Sclerosis 15. May 2026
Search
medline.ch
Multiple Sclerosis
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2199  Previews Next
   
   Articles 1 - 20 / 43974  
   
Psychosis in multiple sclerosis-a narrative review of an underestimated, but clinically significant problem.
J Neural Transm (Vienna)
Olejnik P, Prisco A, Menchetti M, Kasare.
PMID: 42133011 [PubMed - as supplied by publisher]


The Impact of Task-Oriented Training on Health Outcomes in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Am J Phys Med Rehabil
Navas-Otero A, Ortiz Rubio A, Raya-Benítez J, Heredia-Ciuró A, Granados-Santiago M, López-López L, Rodríguez-Martínez MDC.
PMID: 42132414 [PubMed - as supplied by publisher]


Eye movement analysis during working memory tasks correlates with cognitive, clinical, and anatomical metrics in multiple sclerosis.
Mult Scler J Exp Transl Clin
Pardo CF, Fernandez G, Allushi B, Bhaktaram AA, Galleguillos L, Verge D, Pardo G.
PMID: 42131773 [PubMed]


Do apelin and ghrelin play a role in multiple sclerosis? The analysis of patients treated with immunomodulatory therapies.
Front Immunol
Adamczyk B, Morawiec N, Rakoca M, Sowa A, Sawa K, Adamczyk-Sowa M.
PMID: 42131351 [PubMed - indexed for MEDLINE]


Oxidized mannan-MOG35-55 conjugate as a platform for antigen-specific immune modulation in multiple sclerosis.
Front Immunol
Mouzaki A, de Lastic AL, Apostolopoulos V, Matsoukas I.
PMID: 42131329 [PubMed - indexed for MEDLINE]


Serum neurofilament light chain and multiple sclerosis prognosis: a systematic review and meta-analysis.
Front Immunol
Chen Y, Cai M, Lv X.
PMID: 42131327 [PubMed - indexed for MEDLINE]


PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.
JAMIA Open
Demuth S, Faddeenkov I, Paris J, Rousseau O, Baciotti B, Payet M, Casey R, Vukusic S, Doyle S, Jarre G, Vince N, Limou S, De Sèze J, Kerbrat A, Laplaud D, Edan G, Gourraud PA, PRIMUS Consortium.
PMID: 42131074 [PubMed]


Multiple sclerosis diagnosis in south Asia: fundamentals first.
Lancet Reg Health Southeast Asia
The Lancet Regional Health-Southeast Asia.
PMID: 42130678 [PubMed]


Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis.
Neurodegener Dis Manag
Rastkar M, Ghandchi S, Ghajarzadeh M, Ghajarzadeh M.
PMID: 42130400 [PubMed - as supplied by publisher]


Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply.
Lancet Neurol
Sati P, Barkhof F, Reich DS, Ontaneda D, Rovira À.
PMID: 42127925 [PubMed - in process]


Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis.
Lancet Neurol
Sonoda Y, Hagiwara A, Tomizawa Y, Hatano T, Kamagata K.
PMID: 42127924 [PubMed - in process]


Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Lancet Neurol
Zettl UK, Rommer PS, Wattjes MP, Tumani H, Hecker M.
PMID: 42127923 [PubMed - in process]


Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' reply.
Lancet Neurol
Montalban X, Oh J, Coetzee T, Thompson AJ.
PMID: 42127922 [PubMed - in process]


Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Lancet Neurol
Krieger S.
PMID: 42127921 [PubMed - in process]


Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Lancet Neurol
Okuda DT, Kantarci OH, Siva A, Pelletier D, Lebrun-Frénay C, RISConsortium.
PMID: 42127920 [PubMed - in process]


Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Lancet Neurol
Toosy A, Oertel FC, Petzold A, Albrecht P, IMSVISUAL.
PMID: 42127919 [PubMed - in process]


Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
Sellathurai S, Schoenholzer K, Burguet Villena F, Cerdá-Fuertes N, Hofer L, Schaedelin SA, Kana V, Mahenthiran P, D'Souza M, Maleska Maceski A, Derfuss TJ, Oechtering J, Gugleta K, Kappos L, Petzold A, Granziera C, Benkert P, Kuhle J, Papadopoulou A.
PMID: 42127333 [PubMed - indexed for MEDLINE]


Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.
Drugs
Lambe J, Fox RJ.
PMID: 42126690 [PubMed - as supplied by publisher]


Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.
J Neurol
Filippi M, D'Amico E, Brescia Morra V, Zanetta C, Zanghì A, Di Filippo PS, Longobardi E, Colombo E, Mirabella M, Conte A, Tomassini V, Masini C, Perosino V, Tortorella P, Rocca MA, MUPSO Study Group.
PMID: 42126632 [PubMed - indexed for MEDLINE]


Misclassification bias in chronic disease case ascertainment algorithms: a reclassification approach.
Health Promot Chronic Dis Prev Can
Hamm NC, Marrie RA, Jiang D, Irani P, Lix LM.
PMID: 42126353 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 43974    Page 1 of 2199  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1